Literature DB >> 32934075

PD-1 suppresses the maintenance of cell couples between cytotoxic T cells and target tumor cells within the tumor.

Rachel Ambler1, Grace L Edmunds1, Sin Lih Tan1, Silvia Cirillo1, Jane I Pernes1, Xiongtao Ruan2, Jorge Huete-Carrasco1, Carissa C W Wong1, Jiahe Lu1, Juma Ward1, Giulia Toti1, Alan J Hedges1, Simon J Dovedi3, Robert F Murphy2,4,5, David J Morgan6, Christoph Wülfing6.   

Abstract

The killing of tumor cells by CD8+ T cells is suppressed by the tumor microenvironment, and increased expression of inhibitory receptors, including programmed cell death protein-1 (PD-1), is associated with tumor-mediated suppression of T cells. To find cellular defects triggered by tumor exposure and associated PD-1 signaling, we established an ex vivo imaging approach to investigate the response of antigen-specific, activated effector CD8+ tumor-infiltrating lymphocytes (TILs) after interaction with target tumor cells. Although TIL-tumor cell couples readily formed, couple stability deteriorated within minutes. This was associated with impaired F-actin clearing from the center of the cellular interface, reduced Ca2+ signaling, increased TIL locomotion, and impaired tumor cell killing. The interaction of CD8+ T lymphocytes with tumor cell spheroids in vitro induced a similar phenotype, supporting a critical role of direct T cell-tumor cell contact. Diminished engagement of PD-1 within the tumor, but not acute ex vivo blockade, partially restored cell couple maintenance and killing. PD-1 thus contributes to the suppression of TIL function by inducing a state of impaired subcellular organization.
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Year:  2020        PMID: 32934075     DOI: 10.1126/scisignal.aau4518

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  4 in total

1.  Cancer immunotherapy based on image-guided STING activation by nucleotide nanocomplex-decorated ultrasound microbubbles.

Authors:  Xuefeng Li; Sina Khorsandi; Yifan Wang; Julien Santelli; Kristin Huntoon; Nhu Nguyen; Mingming Yang; DaeYong Lee; Yifei Lu; Ruoqi Gao; Betty Y S Kim; Caroline de Gracia Lux; Robert F Mattrey; Wen Jiang; Jacques Lux
Journal:  Nat Nanotechnol       Date:  2022-05-30       Impact factor: 40.523

2.  Adenosine 2A receptor and TIM3 suppress cytolytic killing of tumor cells via cytoskeletal polarization.

Authors:  Grace L Edmunds; Carissa C W Wong; Rachel Ambler; Emily J Milodowski; Hanin Alamir; Stephen J Cross; Gabriella Galea; Christoph Wülfing; David J Morgan
Journal:  Commun Biol       Date:  2022-01-10

Review 3.  Actin Dynamics at the T Cell Synapse as Revealed by Immune-Related Actinopathies.

Authors:  Loïc Dupré; Kaan Boztug; Laurène Pfajfer
Journal:  Front Cell Dev Biol       Date:  2021-06-24

4.  Combined angiogenesis and PD-1 inhibition for immunomodulatory TNBC: concept exploration and biomarker analysis in the FUTURE-C-Plus trial.

Authors:  Song-Yang Wu; Ying Xu; Li Chen; Lei Fan; Xiao-Yan Ma; Shen Zhao; Xiao-Qing Song; Xin Hu; Wen-Tao Yang; Wen-Jun Chai; Xiao-Mao Guo; Xi-Zi Chen; Yan-Hui Xu; Xiao-Yu Zhu; Jian-Jun Zou; Zhong-Hua Wang; Yi-Zhou Jiang; Zhi-Ming Shao
Journal:  Mol Cancer       Date:  2022-03-25       Impact factor: 27.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.